Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Testing Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned
Not recruiting
Investigated Diseases:Investigated Drugs:
+6
Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
Not recruiting
Investigated Diseases:Investigated Drugs:
+9
Study of Domvanalimab and Zimberelimab Combined with Chemotherapy for Previously Untreated Recurrent or Metastatic Head and Neck Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Nimorazole Treatment Based on Hypoxia Profile in Head and Neck Cancer Patients Receiving Radiotherapy with Cisplatin
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Durvalumab, Tremelimumab, and Cisplatin for Patients with Resectable, Locally Advanced Squamous Cell Carcinoma of the Oral Cavity
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma
Not recruiting
Investigated Diseases:
Study of Atezolizumab and Tiragolumab for Patients with Recurrent or Metastatic PD-L1 Positive Head and Neck Squamous Cell Carcinoma
Not recruiting
Investigated Diseases:Investigated Drugs:
